Lay Press
News
The news stories below were collected from sources that used our publications.
New Drug Relieves Back Pain
NEWSMAX, June 23, 2020
Tanezumab Improves Pain, Function in Chronic Low Back Pain
MPR, June 23, 2020
Drug Might Relieve Low Back Pain in Whole New Way
U.S. News & World Report, June 22, 2020
‘Is your pain tolerable?’ Asking may result in less risky pain management
Healio.com, May 8, 2020
Why Rating Pain Isn't Just a Numbers Game
Technologynetworks.com, April 27, 2020
Common painkiller doesn't ease chronic pain after injury
Futurity, September 25, 2018
Common painkiller not effective for chronic pain after traumatic nerve injury
ScienceDaily, September 24, 2017
Reach
Comparison of a Pain Tolerability Question With the Numeric Rating Scale for Assessment of Self-reported Chronic Pain (2020)
Tanezumab for chronic low back pain (2020)
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back (2019)
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial (2018)
Differences in opioid prescribing in low back pain patients with and without depression (2017)
Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication (2015)